CIPLA THROAT NUMBING LOZENGES blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

lidocaine hydrochloride monohydrate, Quantity: 10 mg; dichlorobenzyl alcohol, Quantity: 1.2 mg; amylmetacresol, Quantity: 0.6 mg

Disponible desde:

Cipla Australia Pty Ltd

Designación común internacional (DCI):

Amylmetacresol,Dichlorobenzyl alcohol,lidocaine (lignocaine) hydrochloride monohydrate

formulario farmacéutico:

Lozenge

Composición:

Excipient Ingredients: saccharin sodium; sucrose; quinoline yellow; liquid glucose; Flavour

Vía de administración:

Oral

Unidades en paquete:

8 lozenges, 32 lozenges, 24 lozenges, 16 lozenges

tipo de receta:

Not scheduled. Not considered by committee

indicaciones terapéuticas:

For the symptomatic relief of minor mouth and throat infections, including sore throat and the relief of symptoms of inflammation.

Resumen del producto:

Visual Identification: Yellow colored circular lozenges; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estado de Autorización:

Licence status A

Fecha de autorización:

2014-02-10